Effect of CYP2D6, 2C19, and 3A4 Phenoconversion in Drug-Related Deaths

Sanaa M. Aly,Benjamin Hennart,Jean-Michel Gaulier,Delphine Allorge
DOI: https://doi.org/10.3390/toxics12040260
2024-03-31
Toxics
Abstract:Molecular autopsy is a very important tool in forensic toxicology. However, many determinants, such as co-medication and physiological parameters, should be considered for optimal results. These determinants could cause phenoconversion (PC), a discrepancy between the real metabolic profile after phenoconversion and the phenotype determined by the genotype. This study's objective was to assess the PC of drug-metabolizing enzymes, namely CYP2D6, 2C19, and 3A4, in 45 post-mortem cases where medications that are substrates, inducers, or inhibitors of these enzymes were detected. It also intended to evaluate how PC affected the drug's metabolic ratio (MR) in four cases. Blood samples from 45 cases of drug-related deaths were analyzed to detect and determine drug and metabolite concentrations. Moreover, all the samples underwent genotyping utilizing the HaloPlex Target Enrichment System for CYP2D6, 2C19, and 3A4. The results of the present study revealed a statistically significant rate of PC for the three investigated enzymes, with a higher frequency of poor metabolizers after PC. A compatibility was seen between the results of the genomic evaluation after PC and the observed MRs of venlafaxine, citalopram, and fentanyl. This leads us to focus on the determinants causing PC that may be mainly induced by drug interactions. This complex phenomenon can have a significant impact on the analysis, interpretation of genotypes, and accurate conclusions in forensic toxicology. Nevertheless, more research with more cases in the future is needed to confirm these results.
environmental sciences,toxicology
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to evaluate the phenoconversion (PC) phenomenon of drug - metabolizing enzymes CYP2D6, 2C19 and 3A4 in drug - related deaths and its impact on the metabolic ratio (MR). Specifically, the study aims to: 1. **Evaluate phenoconversion (PC)**: Analyze the phenoconversion of CYP2D6, 2C19 and 3A4 after detecting drugs that are substrates, inducers or inhibitors of these enzymes in 45 cases of drug - related deaths. 2. **Evaluate the impact of PC on the drug metabolic ratio (MR)**: In 4 cases, evaluate how phenoconversion affects the drug metabolic ratio by detecting the concentrations of the parent drug and its main metabolites. ### Research background Genetic polymorphisms of drug - metabolizing enzymes can affect an individual's ability to metabolize drugs, thereby affecting drug responses. The inconsistency between the genotype - predicted phenotype (g - phenotype) and the actual metabolic capacity is called phenoconversion (PC), which may be caused by factors such as age, body weight, gender, disease, food and concomitant medications. Drug - drug interactions (DDIs) and drug - drug - gene interactions (DDGIs) may also lead to PC. ### Research methods - **Sample collection**: Collect femoral vein blood samples from 45 cases of drug - related deaths. - **Toxicological analysis**: Use liquid chromatography - high - resolution mass spectrometry (LC - HRMS) and other methods to detect drugs and their metabolites. - **Genotyping**: Use the HaloPlex targeted enrichment system to genotype CYP2D6, 2C19 and 3A4. - **Phenotype assessment**: Calculate the activity score (AS) based on the genotype and adjust the AS considering drug inhibition or induction factors to determine the phenotype after phenoconversion (p - phenotype). - **Statistical analysis**: Use descriptive statistics and chi - square test to analyze data. ### Main findings - **Frequency of phenoconversion**: The study found that the phenoconversion rates of CYP2D6, 2C19 and 3A4 were statistically significant, especially after phenoconversion, the frequency of poor metabolizers increased significantly. - **Changes in the metabolic ratio (MR)**: In 4 cases, phenoconversion significantly affected the drug metabolic ratio, especially for drugs such as venlafaxine (VEN), fluoxetine (Fen) and citalopram (CIT). ### Conclusion Phenoconversion (PC) is an important phenomenon in drug - related deaths and may significantly affect the drug metabolic ratio (MR). Therefore, in forensic toxicology, considering the impact of PC is crucial for accurately interpreting genotype and metabolic ratio data. More research is needed in the future to further verify these results.